Tissue engineering entails the in vitro construction of bioartificial tissues as well as the in vivo manipulation of cell growth and function using cells isolated from donor tissue and biocompatible scaffold materials. To facilitate effective cell adhesion, migration, and deposition of endogenous extracellular matrix components by the cells, biomaterials for tissue engineering must have regulated surface chemistry, porosity, and biodegradability. To provide a large cell mass that can perform certain differentiated roles required for the tissue build, strategies to switch cells between growth and differentiation, which are mutually exclusive, are applied. The strength of adhesion between cells and substrate, as well as among the many cell types present in the tissue construct, allows combinations of cells and materials to reorganise themselves. Tissue engineering is not frequently used in the care or treatment of patients. Tissue engineering has been employed in skin transplants, cartilage repair, minor artery repair, and bladder repair in a few cases.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Bioherbicides for eco-friendly weed management: From fields to commercialization, constraints and solutions for sustainable agriculture
K R Aneja, Kurukshetra University, India
Title : Predicting wound closure and future segmentation masks in wound healing assays
Alfredo De Cillis, Univeristy of Salento, CNR Nanotec, Italy
Title : Utilizing complex coacervation to promote the controlled crystallization of hydrophobic drugs
Anvesha Subramanian, University of Houston, United States
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States